Alliance A092104: A randomized phase 2/3 study of olaparib plus temozolomide versus investigator’s choice for the treatment of patients with advanced uterine leiomyosarcoma after progression on prior ...

Real-world analyses of BRAF alterations in patients with non-colorectal gastrointestinal cancers. Insulin resistance and impaired insulin secretion and gastrointestinal cancer risk in Korean adults: ...